1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults

Technology appraisal guidance [TA245] Published date: 25 January 2012

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • Appendix A: Appraisal Committee members, guideline representatives and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

7 Related NICE guidance

7 Related NICE guidance

Published

  • Venous thromboembolism: reducing the risk. NICE clinical guideline 92 (2010).

  • Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults. NICE technology appraisal guidance 157 (2008).

  • Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement surgery in adults. NICE technology appraisal guidance 170 (2009).

  • National Institute for Health and Care Excellence (NICE)

  • Next